[1]孟 超,谭雨晴,李 军,等.基于“气-血-阴阳”三期辨治扩张型心肌病[J].陕西中医,2023,(7):922-924.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.022]
 MENG Chao,TAN Yuqing,LI Jun,et al.Differentiation and treatment of dilated cardiomyopathy based on Qi-Blood-Yin and Yang in third stage[J].,2023,(7):922-924.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.022]
点击复制

基于“气-血-阴阳”三期辨治扩张型心肌病
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2023年7期
页码:
922-924
栏目:
学术探讨
出版日期:
2023-07-05

文章信息/Info

Title:
Differentiation and treatment of dilated cardiomyopathy based on Qi-Blood-Yin and Yang in third stage
作者:
孟 超12谭雨晴12李 军1王雪娇1陈恒文1
(1.中国中医科学院广安门医院,北京 100053; 2.北京中医药大学研究生院,北京 100029)
Author(s):
MENG ChaoTAN YuqingLI JunWANG XuejiaoCHEN Hengwen
(Guang'anmen Hospital,China Academy of Chinese Medical Sciences,Beijing 100053,China)
关键词:
扩张型心肌病 心力衰竭 气-血-阴阳 病因病机 病证结合
Keywords:
Dilated cardiomyopathy Heart failure Qi-Blood-Yin and Yang Etiology and pathogenesis Combination of disease and syndrome
分类号:
R 256.2
DOI:
DOI:10.3969/j.issn.1000-7369.2023.07.022
文献标志码:
A
摘要:
根据扩张型心肌病演变规律,病证结合提出“气-血-阴阳”三期辨治扩张型心肌病的临床思路。扩张型心肌病三期,病位由气、血、阴阳不断深入,邪实难祛,正气渐虚,治疗重点由祛邪逐渐转变为扶正。邪实常见痰热、痰浊、瘀血、水饮,祛邪常用辛开苦降、化痰燥湿、活血化瘀、利水渗湿等法,正虚常见气虚、阴虚、阳虚,扶正常用益气养阴、温阳益气、滋阴补阳等法。临证首当辨其病位,定其病性,以明确分期,再遵各期治则治法以遣方用药。
Abstract:
According to the evolution law of dilated cardiomyopathy proposed clinical idea of Qi-Blood-Yin and Yang third stage identification and treatment of dilated cardiomyopathy in combination with the disease evidence.In the third stage of dilated cardiomyopathy,the disease position continues to deepen from Qi,blood,Yin and Yang.The evil was difficult to dispel,healthy Qi was gradually weakened,and focus of treatment gradually changes from dispelling evil to supporting the righteous.Evil facts were common phlegm fever,phlegm turbidity,blood stasis,water drinking,dispelling evil commonly used hard work,phlegm and dampness,blood activation and stasis,water infiltration and other methods,positive deficiency common Qi deficiency,Yin deficiency,Yang deficiency,support normal use of Qi to nourish Yin,warm Yang and Qi,nourish Yin and tonify Yang and other methods.The first thing is to identify location of the disease,determine its disease,so as to clarify the stage,and then follow the treatment rules of each stage to send prescription medicine.

参考文献/References:

[1] 中华医学会心血管病学分会,中国心肌炎心肌病协作组.中国扩张型心肌病诊断和治疗指南[J].临床心血管病杂志,2018,34(5):421-434.
[2] Weintraub RG,Semsarian C,Macdonald P.Dilated cardiomyopathy[J].Lancet,2017,390(10092):400-414.
[3] Liu X,Yu H,Pei J,et al.Clinical characteristics and long-term prognosis in patients with chronic heart failure and reduced ejection fraction in China[J].Heart Lung Circ,2014,23(9):818-826.
[4] Schultheiss HP,Fairweather D,Caforio AP,et al.Dilated cardiomyopathy[J].Nat Rev Dis Primers,2019,5(1):32.
[5] Jordan E,Peterson L,Ai T,et al.Evidence-based assessment of genes in dilated cardiomyopathy[J].Circulation,2021,144(1):7-19.
[6] Rosenbaum AN,Agre KE,Pereira NL.Genetics of dilated cardiomyopathy:Practical implications for heart failure management[J].Nat Rev Cardiol,2020,17(5):286-297.
[7] Tschope C,Ammirati E,Bozkurt B,et al.Myocarditis and inflammatory cardiomyopathy:Current evidence and future directions[J].Nat Rev Cardiol,2021,18(3):169-193.
[8] Bracamonte BW,Cihakova D.Cardiac autoimmunity:Myocarditis[J].Adv Exp Med Biol,2017,100(3):187-221.
[9] 吴西娟,赵养俊.新活素联合地高辛对扩张型心肌病心力衰竭患者心功能及NT-proBNP影响研究[J].陕西医学杂志,2018,47(5):659-661.
[10] 谭雨晴,李 颖,李 军.中医药治疗扩张型心肌病的临床研究现状[J].中华中医药杂志,2019,34(8):3655-3657.
[11] 边汝涛,王振涛.中医药治疗扩张型心肌病的研究进展[J].中西医结合心脑血管病杂志,2019,17(12):1826-1828.
[12] 孟 超,谭雨晴,李 军,等.CiteSpace可视化分析扩张型心肌病研究热点和趋势[J].中国循证心血管医学杂志,2022,14(10):1155-1163.
[13] 吴 琼,董艺丹,王佑华,等.扩心方通过调节TGF-β1/Smad2通路改善扩张型心肌病大鼠心肌纤维化[J].世界科学技术-中医药现代化,2022,24(1):243-251.
[14] 柴松波,王振涛,刘舜禹.抗纤益心方治疗扩张型心肌病气虚血瘀证队列研究[J].陕西中医,2019,40(1):49-51.
[15] 吴 琼,彭珑萍,董艺丹,等.扩心方治疗气阴两虚兼血瘀证扩张型心肌病患者的临床研究[J].中国中医急症,2021,30(11):1940-1943,1946.
[16] 孙语男,李 军.李军教授辨治扩张型心肌病经验[J].中国中医急症,2023,32(2):324-327,342.
[17] 孙语男,李 军.李军教授从“虚、痰、瘀(郁)、热”辨证治疗急性冠脉综合征经验[J].世界中西医结合杂志,2022,17(8):1534-1538.
[18] 孙语男,李 军.李军教授运用“风药”治疗急性冠脉综合征经验[J].中国中医急症,2022,31(11):2023-2026.
[19] 孙语男,李 军.扶阳活血法治疗扩张型心肌病理论探讨[J].中国中医基础医学杂志,2022,28(7):1060-1063,1146.
[20] 于 淼,郭松霖,杨凯晶,等.黄芪及其制剂治疗心力衰竭的研究进展[J].中医药学报,2021,49(6):94-99.

相似文献/References:

[1]岳珍珍,何胜男,焦义明.振源胶囊联合心理干预治疗慢性心衰疗效及对患者情绪影响*[J].陕西中医,2019,(3):300.
 YUE Zhenzhen,HE Shengnan,JIAO Yiming..Effect of Zhenyuan capsule combined with psychological intervention on efficacy, safety and negative emotions of chronic heart failure[J].,2019,(7):300.
[2]柴松波,王振涛,刘舜禹.抗纤益心方治疗扩张型心肌病气虚血瘀证队列研究*[J].陕西中医,2019,(1):49.
[3]宋金玉,杜 鑫,施继红,等.芪苈强心胶囊联合米力农对心肌梗死合并心力衰竭患者动脉血流和心功能的影响*[J].陕西中医,2020,(4):493.
[4]朱舜明,张学军,张荣怀,等.生脉注射液联合靶剂量比索洛尔对高血压伴心力衰竭患者血管内皮功能和心功能的影响*[J].陕西中医,2020,(10):1403.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.017]
 ZHU Shunming,ZHANG Xuejun,ZHANG Ronghuai,et al.Effects of Shengmai injection combined with target dose bisoprolol on vascular endothelial function and cardiac function in patients with hypertension and heart failure[J].,2020,(7):1403.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.017]
[5]董其浩,邓 兵.益脉强心汤对冠心病合并心衰患者心室重构及血清血小板活化因子、转化生长因子-β1的影响[J].陕西中医,2021,(7):883.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.018]
[6]张阳阳,孙 琮,杨兴嫕,等.炙甘草汤加减联合依那普利治疗慢性阻塞性肺疾病合并心力衰竭疗效研究[J].陕西中医,2021,(9):1219.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.017]
 ZHANG Yangyang,SUN Cong,YANG Xingyi,et al.Efficacy study on modified Zhigancao decoction combined with enalapril in treatment of chronic obstructive pulmonary disease with heart failure[J].,2021,(7):1219.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.017]
[7]宋晓龙,宋 俊,潘仁友,等.利心水方治疗冠心病心力衰竭疗效及对患者心肌纤维化、心肌重构的影响[J].陕西中医,2022,(2):197.[doi:DOI:10.3969/j.issn.1000-7369.2022.02.013]
[8]张 妍,周纳纳,韩 茹,等.益心附葶饮对主动脉缩窄大鼠心肌纤维化及p38MAPK/NF-κB p65信号通路的影响[J].陕西中医,2022,(3):287.[doi:DOI:10.3969/j.issn.1000-7369.2022.03.004]
 ZHANG Yan,ZHOU Nana,HAN Ru,et al.Effect of Yixin Futing Yin on myocardial fibrosis and p38MAPK/NF-κB p65 signaling pathway in rats with aortic constriction inhibitory[J].,2022,(7):287.[doi:DOI:10.3969/j.issn.1000-7369.2022.03.004]
[9]衣雪锋,汪远军,阮晓冬.温阳复脉益心汤治疗心力衰竭合并房颤疗效研究[J].陕西中医,2024,(7):909.[doi:DOI:10.3969/j.issn.1000-7369.2024.07.010]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(81973836); 首都卫生发展科研专项重点攻关项目(2020-1-4151); 北京市中医药科技发展资金资助项目(JJ-2020-69); 中国中医科学院中医药科技重大成果引导项目(ZZ13-ZD-04)
更新日期/Last Update: 2023-07-10